Glutathione Research Review: Human Clinical Trials, Liver, NAFLD & Oxidative Stress Evidence
Glutathione: Comprehensive Review of Human Clinical Research
Abstract: This review summarizes peer-reviewed human clinical trials evaluating glutathione (GSH) in oxidative stress, hepatic function, metabolic syndrome, cardiovascular health and neurological research. Evidence includes randomized controlled trials, systematic reviews and clinical cohort studies conducted in defined patient populations.
Glutathione (GSH) is a tripeptide composed of glutamate, cysteine, and glycine. It is one of the most extensively studied endogenous antioxidants in human physiology and plays a central role in redox balance, detoxification, mitochondrial regulation, immune signaling, and cellular protection.
Biochemical Mechanism and Cellular Role
- Neutralization of reactive oxygen species (ROS)
- Regeneration of vitamins C and E
- Participation in glutathione peroxidase reactions
- Phase II hepatic detoxification conjugation
- Maintenance of mitochondrial redox balance
- Regulation of NF-κB inflammatory signaling pathways
Depletion of intracellular glutathione has been associated with aging, chronic disease, metabolic dysfunction, and inflammatory states.
Human Clinical Research on Oxidative Stress
Randomized c
Oxidative stress mechanisms are also discussed in our L-Carnitine clinical research review, which explores mitochondrial fatty acid transport and cardiac remodeling studies.
ontrolled trials have demonstrated that glutathione supplementation can influence oxidative stress markers in defined populations.
- Reduction in malondialdehyde (MDA) levels
- Increased total antioxidant capacity (TAC)
- Improved glutathione redox ratio (GSH:GSSG)
Example Study: A randomized controlled trial demonstrated increased systemic glutathione levels and reduced oxidative stress markers after oral supplementation (Richie et al., 2015, European Journal of Nutrition).
Glutathione and Liver Function (NAFLD & Hepatic Research)
Glutathione is highly concentrated in hepatic tissue and plays a key role in detoxification pathways and protection against oxidative injury.
Non-Alcoholic Fatty Liver Disease (NAFLD)
A clinical study evaluating oral glutathione administration in NAFLD patients demonstrated:
- Reduction in ALT (alanine aminotransferase)
- Reduction in AST (aspartate aminotransferase)
- Improved hepatic fat markers in selected participants
Reference: Honda et al., 2017, BMC Gastroenterology – Oral glutathione improved liver function parameters in NAFLD patients.
Hepatic Detoxification Support
- Support of phase II conjugation pathways
- Protection against oxidative hepatocellular damage
- Observed improvement in liver enzyme profiles in clinical cohorts
Metabolic Syndrome and Insulin Sensitivity
Research has demonstrated a correlation between low glutathione status and insulin resistance.
- Lower GSH levels observed in individuals with type 2 diabetes
- Improvement in oxidative markers in metabolic syndrome cohorts
- Reduction in inflammatory cytokines in controlled trials
Clinical Evidence: Sekhar et al., 2011 (American Journal of Clinical Nutrition) reported that improving cysteine availability restored glutathione levels and improved oxidative stress parameters in older adults.
Cardiovascular and Endothelial Function Research
Glutathione plays a role in nitric oxide preservation and vascular redox stability.
- Improved endothelial-dependent vasodilation in certain studies
- Reduction in oxidized LDL markers
- Association with improved vascular oxidative balance
Study Example: Clinical investigations have reported that intravenous glutathione improved endothelial function in patients with coronary artery disease under supervised settings.
Neurological Research and Mitochondrial Health
Reduced glutathione levels have been documented in neurodegenerative conditions.
- Lower GSH levels observed in Parkinson’s disease patients
- Mitochondrial dysfunction linked to oxidative depletion
- Intravenous glutathione evaluated in early-stage Parkinson’s clinical trials
Reference: Hauser et al., 2009 – Pilot study of intravenous glutathione in Parkinson’s disease demonstrated safety and observed symptomatic changes under medical supervision.
Dosing Ranges Observed in Human Studies
- 250–1000 mg/day in oral oxidative stress trials
- 500–2000 mg/day in metabolic and liver studies
- Intravenous administration studied in clinical settings only
Study duration ranges from 4 weeks to several months depending on protocol.
Key Research Findings Summary
- Glutathione is a central intracellular antioxidant regulating redox balance.
- Human trials demonstrate reductions in oxidative stress biomarkers.
- NAFLD research shows improvements in liver enzymes.
- Metabolic studies suggest improved oxidative parameters in insulin-resistant populations.
- Cardiovascular studies demonstrate endothelial function modulation.
- Neurological research indicates potential mitochondrial protective roles.
Selected Peer-Reviewed References
- Richie JP et al., 2015. Randomized controlled trial of oral glutathione supplementation. European Journal of Nutrition.
- Honda Y et al., 2017. Oral glutathione in NAFLD patients. BMC Gastroenterology.
- Sekhar RV et al., 2011. Glutathione deficiency in aging and diabetes. American Journal of Clinical Nutrition.
- Hauser RA et al., 2009. Intravenous glutathione in Parkinson’s disease. Movement Disorders Journal.
Educational and Research Notice
This article summarizes findings from peer-reviewed human clinical research conducted in defined medical populations under controlled supervision. It is provided strictly for scientific and educational purposes. Any products sold on this website are designated for laboratory research use only and are not intended for human or veterinary consumption.
Frequently Asked Questions — Research Highlights
What does this research show?
This summary explains human clinical trial outcomes on metabolic, cardiovascular, or oxidative mechanisms explored in peer-reviewed literature.
Are these products for human consumption?
No. All products on this website are for laboratory research use only and are not intended for human or veterinary use.